ShockWave Medical Inc. (SWAV)
NASDAQ: SWAV
· Real-Time Price · USD
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 10:00 PM
ShockWave Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 787.97M | 730.23M | 671.28M | 616.59M | 557.17M | 489.73M | 429.89M | 363.71M | 298.88M | 237.15M | 175.68M | 130.11M | 84.49M |
Cost of Revenue | 102.53M | 95.39M | 87.57M | 80.94M | 73.17M | 65M | 60.16M | 53.23M | 46.44M | 41.44M | 35.25M | 29.57M | 23.23M |
Gross Profit | 685.44M | 634.84M | 583.7M | 535.65M | 484M | 424.74M | 369.73M | 310.48M | 252.44M | 195.71M | 140.43M | 100.54M | 61.26M |
Operating Income | 162.99M | 160.39M | 158.23M | 151.37M | 148.58M | 124.13M | 95.69M | 61.74M | 31.99M | -871K | -30.72M | -46.34M | -64.17M |
Interest Income | 15.64M | 3.96M | 4.92M | 2.73M | 1.92M | 1.28M | 316K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 183.54M | 174.28M | 163.47M | 153.52M | 146.85M | 120.83M | 89.22M | 56.13M | 29.44M | -8.84M | -37.75M | -52.68M | -70.42M |
Net Income | 163.5M | 147.28M | 243.88M | 243.9M | 240.6M | 216M | 88.03M | 54.97M | 28.99M | -9.14M | -37.95M | -52.83M | -70.53M |
Selling & General & Admin | 360.61M | 330.1M | 298.42M | 276.58M | 243.79M | 218.92M | 201.37M | 182.51M | 163.17M | 146.03M | 126.28M | 107.85M | 90.12M |
Research & Development | 163.14M | 145.65M | 127.05M | 107.7M | 91.63M | 81.68M | 72.67M | 66.23M | 57.29M | 50.54M | 44.87M | 39.03M | 35.31M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -310K | -523K | -803K | -657K | -582K | -55K | 443K | 517K |
Operating Expenses | 522.45M | 474.45M | 425.47M | 384.28M | 335.42M | 300.6M | 274.04M | 248.74M | 220.45M | 196.58M | 171.15M | 146.88M | 125.43M |
Interest Expense | 9.21M | 6.91M | 4.92M | 2.73M | 2.23M | 1.89M | 1.22M | 1.07M | 1.08M | 1.1M | 1.11M | 1.26M | 1.25M |
Selling & Marketing Expenses | 255.32M | 234.84M | 211.09M | 196.27M | 180.04M | 162M | 151.75M | 138.06M | 123.26M | 111.29M | 94.53M | 79.76M | 65.25M |
Cost & Expenses | 624.98M | 569.84M | 513.04M | 465.21M | 408.59M | 365.6M | 334.2M | 301.97M | 266.89M | 238.02M | 206.4M | 176.45M | 148.66M |
Income Tax Expense | 20.04M | 27M | -80.41M | -90.39M | -93.75M | -95.17M | 1.2M | 1.16M | 454K | 301K | 202K | 153K | 101K |
Shares Outstanding (Basic) | 37.28M | 36.93M | 36.8M | 36.66M | 36.43M | 36.18M | 37.95M | 35.83M | 37.23M | 35.35M | 35.21M | 35.03M | 34.71M |
Shares Outstanding (Diluted) | 38.47M | 38.16M | 38.2M | 38.23M | 37.98M | 37.99M | 37.95M | 37.69M | 37.62M | 37.61M | 37.57M | 35.03M | 34.8M |
EPS (Basic) | 4.42 | 4.01 | 6.70 | 6.67 | 6.59 | 5.91 | 2.39 | 1.53 | 0.81 | -0.26 | -1.09 | -1.53 | -2.08 |
EPS (Diluted) | 4.28 | 3.87 | 6.42 | 6.42 | 6.34 | 5.70 | 2.33 | 1.46 | 0.77 | -0.3 | -1.1 | -1.53 | -2.08 |
EBITDA | 188.12M | 173.44M | 172.95M | 159.04M | 152.97M | 128.34M | 96.19M | 63.17M | 35.86M | -2.99M | -33.56M | -48.97M | -66.38M |
EBIT | 192.75M | 181.19M | 168.4M | 156.25M | 149.07M | 122.71M | 90.44M | 57.19M | 30.52M | -7.74M | -36.64M | -51.42M | -69.18M |
Depreciation & Amortization | 11.76M | 10.21M | 10.33M | 6M | 836K | 640K | -893K | 1.91M | 5.77M | 5.54M | 4.75M | 4.12M | 3.68M |